Literature DB >> 24840244

Predicting response to neoadjuvant therapy for rectal cancer.

S Pucciarelli1, L Bacigalupo, I Maretto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24840244     DOI： 10.1007/s10151-014-1162-8

Source DB:  PubMed          Journal:  Tech Coloproctol        ISSN： 1123-6337            Impact factor:   3.781


× No keyword cloud information.
  9 in total

Review 1.  Prediction in rectal cancer.

Authors:  Eliane C M Zeestraten; Peter J K Kuppen; Cornelis J H van de Velde; Corrie A M Marijnen
Journal:  Semin Radiat Oncol       Date:  2012-04       Impact factor: 5.934

2.  Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial.

Authors:  Salvatore Pucciarelli; Antonino De Paoli; Mario Guerrieri; Giuseppe La Torre; Isacco Maretto; Francesco De Marchi; Giovanna Mantello; Maria Antonietta Gambacorta; Vincenzo Canzonieri; Donato Nitti; Vincenzo Valentini; Claudio Coco
Journal:  Dis Colon Rectum       Date:  2013-12       Impact factor: 4.585

3.  Repeatability of diffusion-weighted imaging in rectal cancer.

Authors:  Martijn Intven; Onne Reerink; Marielle E P Philippens
Journal:  J Magn Reson Imaging       Date:  2013-10-11       Impact factor: 4.813

4.  Predicting complete response to neoadjuvant CRT for distal rectal cancer using sequential PET/CT imaging.

Authors:  R O Perez; A Habr-Gama; G P São Julião; P B Lynn; C Sabbagh; I Proscurshim; F G Campos; J Gama-Rodrigues; S C Nahas; C A Buchpiguel
Journal:  Tech Coloproctol       Date:  2014-02-08       Impact factor: 3.781

5.  Clinical criteria underestimate complete pathological response in rectal cancer treated with neoadjuvant chemoradiotherapy.

Authors:  Fraser M Smith; Homer Wiland; Adam Mace; Rish K Pai; Matthew F Kalady
Journal:  Dis Colon Rectum       Date:  2014-03       Impact factor: 4.585

6.  Telomere-specific reverse transcriptase (hTERT) and cell-free RNA in plasma as predictors of pathologic tumor response in rectal cancer patients receiving neoadjuvant chemoradiotherapy.

Authors:  Salvatore Pucciarelli; Enrica Rampazzo; Marta Briarava; Isacco Maretto; Marco Agostini; Maura Digito; Sonia Keppel; Maria Luisa Friso; Sara Lonardi; Antonino De Paoli; Claudia Mescoli; Donato Nitti; Anita De Rossi
Journal:  Ann Surg Oncol       Date:  2012-03-07       Impact factor: 5.344

7.  Development and external validation of a predictive model for pathological complete response of rectal cancer patients including sequential PET-CT imaging.

Authors:  Ruud G P M van Stiphout; Guido Lammering; Jeroen Buijsen; Marco H M Janssen; Maria Antonietta Gambacorta; Pieter Slagmolen; Maarten Lambrecht; Domenico Rubello; Marcello Gava; Alessandro Giordano; Eric O Postma; Karin Haustermans; Carlo Capirci; Vincenzo Valentini; Philippe Lambin
Journal:  Radiother Oncol       Date:  2010-12-20       Impact factor: 6.280

8.  Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study.

Authors:  Doenja M J Lambregts; Vincent Vandecaveye; Brunella Barbaro; Frans C H Bakers; Maarten Lambrecht; Monique Maas; Karin Haustermans; Vincenzo Valentini; Geerard L Beets; Regina G H Beets-Tan
Journal:  Ann Surg Oncol       Date:  2011-02-23       Impact factor: 5.344

9.  Repeatability of the Maximum Standard Uptake Value (SUVmax) in FDG PET.

Authors:  Henry Lindholm; Johan Staaf; Hans Jacobsson; Fredrik Brolin; Robert Hatherly; Alejandro Sânchez-Crespo
Journal:  Mol Imaging Radionucl Ther       Date:  2014-02-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.